DC cell based on LMP-1 antigen, targeting immune cell population, preparation method and applications thereof
An LMP-1, cell technology, applied to other methods of inserting foreign genetic material, cells modified by introducing foreign genetic material, animal cells, etc., can solve the problem of immune cell preparation methods need to be improved, and achieve the problem of cytotoxicity , high efficiency, high transfection efficiency
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0065] 1. Materials and equipment
[0066] 1. Laboratory level: GLP
[0067] 2. Instruments and equipment:
[0068] Negative 80-degree ultra-low temperature refrigerator (Zhongke Meiling, DW-HL388); ordinary refrigerator (Haier, double door, -20°C and 4°C); mold incubator (Shanghai Boxun, MJX-160B-Z); constant temperature water bath ( SSW-420-2S); CO 2 Incubator (HF240); low-speed centrifuge (Shanghai Anting, TDL-40C); inverted biological microscope (Kexin, model: BLD-1); biological safety cabinet (Suzhou purification, double); Rand) 1-10ml; 1 set of micropipettes (Dalong), 4 pieces; programmed cooling box (Thermo); liquid nitrogen tank (Jinfeng, YDS-120-216); PCR instrument; gel electrophoresis imaging system ; Electrophoresis apparatus; Thermostat;
[0069] 3. Cell culture consumables:
[0070] Cell culture bag (Takara company); 75cm 2 Culture bottle, 175cm 2 Culture bottle, 1.8ml cryopreservation tube, 1.5ml EP tube, 50ml centrifuge tube, and 15ml centrifuge tube are...
Embodiment 2
[0132] Embodiment 2: clinical treatment
[0133] The CTL cells prepared in Example 1 were reinfused into the patient, and the reinfusion effect was observed, as follows:
[0134] 20 LMP-1 positive herpes virus patients were divided into 2 groups (10 people in group A and 10 people in group B), wherein, for group A, according to the method in Example 1, a sufficient amount was obtained on the 14th day and the 15th day After CTL cells, reinfuse the patient, and the amount of cells reinfused each time is 1~2*10 9 ; Group B did not reinfuse cells (as a control). One blood collection and two consecutive reinfusions constituted a course of treatment. After 3 courses of treatment, observation was carried out.
[0135] The results showed that there was a significant difference between group A and group B. After reinfusion, all patients in group A felt less tired, increased appetite, less pain, and increased weight. Among them, 6 patients had less symptoms of herpes virus infection;...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com